Therapeutic Strategies Targeting the Kidney-Liver-Immune-Heart Network: Circadian and Mechanosensory Pathways in

Yuya Yoshida1, Kohei Fukuoka1, Tomohito Tanihara1

  • 1Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan.

Insights

Hepatic clock-controlled vitamin A metabolism influences immune cell clock genes via retinoic acid signaling. Mechanosensory pathways, like G protein-coupled receptor 68, also link mechanical forces to inflammation in kidney disease-related heart injury.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Chronobiology

Background:

  • Vitamin A (retinoid) metabolism involves a cross-organ axis influenced by the liver's circadian clock.
  • Mechanosensory signaling integrates hemodynamic forces with tissue microenvironment cues.
  • Chronic kidney disease (CKD) can lead to cardiac injury, involving complex signaling pathways.

Purpose of the Study:

  • To review the role of hepatic retinoid metabolism in immune clock gene expression.
  • To highlight mechanosensory signaling pathways in integrating mechanical and inflammatory cues.
  • To discuss therapeutic strategies for CKD-associated cardiac injury.

Main Methods:

  • Review of existing literature on retinoid metabolism, circadian rhythms, and mechanosensory signaling.
  • Discussion of signaling pathways including Janus kinase 2-signal transducer and activator of transcription 5 (JAK2-STAT5).
  • Focus on G protein-coupled receptor 68 (GPCR68) as a druggable target.

Main Results:

  • Hepatic clock-dependent retinoid handling may promote pro-inflammatory monocyte states via retinoic acid-JAK2-STAT5 signaling.
  • Mechanosensory signaling, exemplified by GPCR68, links mechanical forces to inflammation.
  • GPCR68 is identified as a key node in CKD-associated cardiac inflammation.

Conclusions:

  • Circadian alignment, retinoid metabolism modulation, and targeted inhibition of immune/mechanosensory pathways are potential therapeutic avenues.
  • Understanding the interplay between retinoid metabolism, circadian clocks, and mechanosensing is crucial for treating inflammatory conditions.
  • Targeting GPCR68 offers a potential strategy for mitigating cardiac injury in CKD.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
682
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.3K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K